ArticleCureus2026

Myelodysplastic Syndrome Secondary to Chimeric Antigen Receptor T-cell (CAR-T) Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma.

Waqqas Tai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.